315 related articles for article (PubMed ID: 21255869)
21. Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma.
Chalermchai T; Rummaneethorn P
J Cosmet Laser Ther; 2018 Jun; 20(3):134-139. PubMed ID: 29020467
[TBL] [Abstract][Full Text] [Related]
22. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
Basit A; Rahman A; Uddin R
J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
[TBL] [Abstract][Full Text] [Related]
23. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study.
Wanitphakdeedecha R; Sy-Alvarado F; Patthamalai P; Techapichetvanich T; Eimpunth S; Manuskiatti W
Lasers Med Sci; 2020 Dec; 35(9):2015-2021. PubMed ID: 32506227
[TBL] [Abstract][Full Text] [Related]
24. Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma.
Torok HM; Jones T; Rich P; Smith S; Tschen E
Cutis; 2005 Jan; 75(1):57-62. PubMed ID: 15732437
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma.
Ibrahim ZA; Gheida SF; El Maghraby GM; Farag ZE
J Cosmet Dermatol; 2015 Jun; 14(2):113-23. PubMed ID: 25847063
[TBL] [Abstract][Full Text] [Related]
27. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy.
Cestari TF; Hexsel D; Viegas ML; Azulay L; Hassun K; Almeida AR; Rêgo VR; Mendes AM; Filho JW; Junqueira H
Br J Dermatol; 2006 Dec; 156 Suppl 1():13-20. PubMed ID: 17176300
[TBL] [Abstract][Full Text] [Related]
28. Single-session intense pulsed light combined with stable fixed-dose triple combination topical therapy for the treatment of refractory melasma.
Figueiredo Souza L; Trancoso Souza S
Dermatol Ther; 2012; 25(5):477-80. PubMed ID: 23046029
[TBL] [Abstract][Full Text] [Related]
29. Assessment of combined fractional CO
Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
[TBL] [Abstract][Full Text] [Related]
30. The efficacy in melasma treatment using a 1410 nm fractional photothermolysis laser.
Wanitphakdeedecha R; Keoprasom N; Eimpunth S; Manuskiatti W
J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):293-7. PubMed ID: 23347253
[TBL] [Abstract][Full Text] [Related]
31. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
Adalatkhah H; Sadeghi-Bazargani H
Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a Low Energy, Low Density, Non-Ablative Fractional 1927 nm Wavelength Laser for Facial Skin Resurfacing.
Brauer JA; Alabdulrazzaq H; Bae YS; Geronemus RG
J Drugs Dermatol; 2015 Nov; 14(11):1262-7. PubMed ID: 26580875
[TBL] [Abstract][Full Text] [Related]
33. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma.
Chan R; Park KC; Lee MH; Lee ES; Chang SE; Leow YH; Tay YK; Legarda-Montinola F; Tsai RY; Tsai TH; Shek S; Kerrouche N; Thomas G; Verallo-Rowell V
Br J Dermatol; 2008 Sep; 159(3):697-703. PubMed ID: 18616780
[TBL] [Abstract][Full Text] [Related]
34. Combination of a 755-nm picosecond laser and hydroquinone 2% cream versus hydroquinone 2% cream alone for the treatment of melasma: A randomized, split-face, and controlled trial.
Manuskiatti W; Yan C; Gulfan MCB; Techapichetvanich T; Wanitphakdeedecha R
Lasers Surg Med; 2022 Dec; 54(10):1245-1250. PubMed ID: 36345697
[TBL] [Abstract][Full Text] [Related]
35. Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial.
Mokhtari F; Bahrami B; Faghihi G; Asilian A; Iraji F
J Dermatolog Treat; 2022 Aug; 33(5):2475-2481. PubMed ID: 34387527
[TBL] [Abstract][Full Text] [Related]
36. Community-based trial of a triple-combination agent for the treatment of facial melasma.
Grimes P; Kelly AP; Torok H; Willis I
Cutis; 2006 Mar; 77(3):177-84. PubMed ID: 16610738
[TBL] [Abstract][Full Text] [Related]
37. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
[TBL] [Abstract][Full Text] [Related]
38. Melasma--updated treatments.
Situm M; Kolić M; Bolanca Z; Ljubicić I; Misanović B
Coll Antropol; 2011 Sep; 35 Suppl 2():315-8. PubMed ID: 22220462
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of combination of glycolic acid peeling with topical regimen in treatment of melasma.
Chaudhary S; Dayal S
J Drugs Dermatol; 2013 Oct; 12(10):1149-53. PubMed ID: 24085051
[TBL] [Abstract][Full Text] [Related]
40. Rationale for the use of topical corticosteroids in melasma.
Menter A
J Drugs Dermatol; 2004; 3(2):169-74. PubMed ID: 15098972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
